BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 34831167)

  • 1. Mechanisms, Diagnosis and Treatment of Bone Metastases.
    Ban J; Fock V; Aryee DNT; Kovar H
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic targets for cancer bone metastasis.
    Krzeszinski JY; Wan Y
    Trends Pharmacol Sci; 2015 Jun; 36(6):360-73. PubMed ID: 25962679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metastasis and the metastatic niche.
    Ren G; Esposito M; Kang Y
    J Mol Med (Berl); 2015 Nov; 93(11):1203-12. PubMed ID: 26275789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis.
    Park SH; Keller ET; Shiozawa Y
    Calcif Tissue Int; 2018 Feb; 102(2):152-162. PubMed ID: 29094177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming immunosuppression in bone metastases.
    Reinstein ZZ; Pamarthy S; Sagar V; Costa R; Abdulkadir SA; Giles FJ; Carneiro BA
    Crit Rev Oncol Hematol; 2017 Sep; 117():114-127. PubMed ID: 28600175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the metastatic niche: targeting the microenvironment.
    Guise T
    Semin Oncol; 2010 Oct; 37 Suppl 2():S2-14. PubMed ID: 21111245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy options for treatment of bone metastases; beyond bisphosphonates.
    Buijs JT; Kuijpers CC; van der Pluijm G
    Curr Pharm Des; 2010; 16(27):3015-27. PubMed ID: 20722621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow/bone pre-metastatic niche for breast cancer cells colonization: The role of mesenchymal stromal cells.
    Sanmartin MC; Borzone FR; Giorello MB; Pacienza N; Yannarelli G; Chasseing NA
    Crit Rev Oncol Hematol; 2021 Aug; 164():103416. PubMed ID: 34237436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor-stromal interactions in bone metastasis.
    Esposito M; Kang Y
    Pharmacol Ther; 2014 Feb; 141(2):222-33. PubMed ID: 24140083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic Microenvironment and Metastatic Bone Disease.
    Hiraga T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.
    Schmid-Alliana A; Schmid-Antomarchi H; Al-Sahlanee R; Lagadec P; Scimeca JC; Verron E
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29300334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.
    Brisset JC; Hoff BA; Chenevert TL; Jacobson JA; Boes JL; Galbán S; Rehemtulla A; Johnson TD; Pienta KJ; Galbán CJ; Meyer CR; Schakel T; Nicolay K; Alva AS; Hussain M; Ross BD
    PLoS One; 2015; 10(4):e0123877. PubMed ID: 25859981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.
    Tulotta C; Lefley DV; Freeman K; Gregory WM; Hanby AM; Heath PR; Nutter F; Wilkinson JM; Spicer-Hadlington AR; Liu X; Bradbury SMJ; Hambley L; Cookson V; Allocca G; Kruithof de Julio M; Coleman RE; Brown JE; Holen I; Ottewell PD
    Clin Cancer Res; 2019 May; 25(9):2769-2782. PubMed ID: 30670488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures.
    Marlow R; Dontu G
    Methods Mol Biol; 2015; 1293():213-20. PubMed ID: 26040690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone metastases.
    Coleman RE; Croucher PI; Padhani AR; Clézardin P; Chow E; Fallon M; Guise T; Colangeli S; Capanna R; Costa L
    Nat Rev Dis Primers; 2020 Oct; 6(1):83. PubMed ID: 33060614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.
    Shiozawa Y; Pienta KJ; Taichman RS
    Clin Cancer Res; 2011 Sep; 17(17):5553-8. PubMed ID: 21676926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel model of dormancy for bone metastatic breast cancer cells.
    Marlow R; Honeth G; Lombardi S; Cariati M; Hessey S; Pipili A; Mariotti V; Buchupalli B; Foster K; Bonnet D; Grigoriadis A; Rameshwar P; Purushotham A; Tutt A; Dontu G
    Cancer Res; 2013 Dec; 73(23):6886-99. PubMed ID: 24145351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis.
    Kähkönen TE; Halleen JM; Bernoulli J
    Cells; 2021 Jun; 10(6):. PubMed ID: 34204474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer.
    Quayle L; Ottewell PD; Holen I
    Curr Cancer Drug Targets; 2015; 15(6):469-80. PubMed ID: 25968899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.